Efalizumab-induced autoimmune pancytopenia

W L Tom1, M D Miller, M Y Hurley

  • 1Department of Dermatology, Saint Louis University School of Medicine, 1402 South Grand Blvd, MO 63104, USA.

Summary

Efalizumab, a psoriasis treatment, can cause immune-mediated pancytopenia, a rare but serious blood disorder. Patients require close monitoring of blood cell counts during therapy.